These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11558468)

  • 1. Amiodarone before electrical cardioversion of atrial fibrillation.
    Veloso HH
    Am J Cardiol; 2001 Aug; 88(4):466. PubMed ID: 11558468
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.
    Van Noord T; Van Gelder IC; Schoonderwoerd BA; Crijns HJ
    Am J Cardiol; 2000 Dec; 86(12):1384-5, A5. PubMed ID: 11113420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation control and cardioversion.
    Harrison RA; Liratsopulos G
    Lancet; 2001 Apr; 357(9262):1127-8. PubMed ID: 11303604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic atrial fibrillation in adults: direct current cardioversion or medical cardioversion].
    Fradi I; Mokaddem A; Selmi K; Boujnah MR
    Tunis Med; 2006 Dec; 84(12):772-6. PubMed ID: 17288278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of patients with atrial fibrillation who undergo electrical cardioversion.
    Stabile G; Turco P; De Simone A
    Circulation; 2003 Mar; 107(11):e75; author reply e75. PubMed ID: 12654622
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of amiodarone treatment on outcome after direct current cardioversion in atrial fibrillation: should we cardiovert atrial fibrillation of longer duration.
    Agarwal SC; Pepper CB
    Int J Cardiol; 2007 May; 117(3):406-7. PubMed ID: 16904207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative effects of amiodarone, diltiazem, and atenolol on results of electrical cardioversion in patients with chronic atrial fibrillation].
    Kanorskiĭ SG; Zingilevskiĭ KB
    Kardiologiia; 2002; 42(8):44-5. PubMed ID: 12494094
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal timing of electrical cardioversion in patients with persistent atrial fibrillation.
    Naji F; Vokac D; Kanic V; Sabovic M
    Med Sci Monit; 2010 Oct; 16(10):CR464-8. PubMed ID: 20885349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical questions #5: Maintenance of normal sinus rhythm after cardioversion: is amiodarone better than placebo?
    Fuh A; Feldstein DA
    WMJ; 2005 Sep; 104(7):17-8. PubMed ID: 16294592
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioversion of atrial fibrillation.
    Jolobe OM
    Postgrad Med J; 1996 Feb; 72(844):126. PubMed ID: 8871469
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation.
    Kanoupakis EM; Manios EG; Mavrakis HE; Tzerakis PG; Mouloudi HK; Vardas PE
    Am J Cardiol; 2004 Sep; 94(5):659-62. PubMed ID: 15342304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs to promote sinus rhythm reversion and maintenance in atrial fibrillation--why amiodarone is better.
    Nattel S
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):5-6. PubMed ID: 12916518
    [No Abstract]   [Full Text] [Related]  

  • 15. Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
    Gorenek B; Cavusoglu Y; Goktekin O; Birdane A; Kudaiberdieva G; Ata N; Unalir A; Timuralp B
    Int J Cardiol; 2006 Jan; 106(2):268-9. PubMed ID: 16321704
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardioversion threshold, IRAF and beyond.
    Merckx KL; Tieleman RG; Crijns HJ
    Eur Heart J; 2004 Jun; 25(11):997. PubMed ID: 15172478
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone.
    Tieleman RG; Gosselink AT; Crijns HJ; van Gelder IC; van den Berg MP; de Kam PJ; van Gilst WH; Lie KI
    Am J Cardiol; 1997 Jan; 79(1):53-7. PubMed ID: 9024736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM;
    Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients.
    Pandozi C; Gentilucci G; Calò L; Castro A; Lamberti F; Loricchio ML; Santini L; Magris B; Bulava A; Peichl P; Santini M
    Ital Heart J; 2003 Apr; 4(4):257-63. PubMed ID: 12784779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation.
    Kosior DA; Wozakowska-Kapłon B; Jasik M; Kiliszek M; Rabczenko D; Opolski G
    Kardiol Pol; 2005 Dec; 63(6):585-92; discussion 593-4. PubMed ID: 16380855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.